| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |